Detalles de la búsqueda
1.
MATWIN: bridging the gap between academic research and industry.
Hum Genomics
; 9: 23, 2015 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26377789
2.
ELN 2013 response status criteria: relevance for de novo imatinib chronic phase chronic myeloid leukemia patients?
Am J Hematol
; 90(1): 37-41, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25293449
3.
Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy.
Haematologica
; 99(3): 458-64, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24362549
4.
CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) ß2, and prevents death-inducing signaling complex formation.
Proc Natl Acad Sci U S A
; 108(47): 19072-7, 2011 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-22065776
5.
Long-term safety and efficacy of imatinib mesylate (Gleevec®) in elderly patients with chronic phase chronic myelogenous leukemia: results of the AFR04 study.
Am J Hematol
; 88(1): 1-4, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22987312
6.
Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function.
Am J Pathol
; 178(5): 1986-98, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21514416
7.
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.
Blood
; 116(17): 3157-62, 2010 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20479285
8.
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.
Lancet Oncol
; 11(11): 1029-35, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20965785
9.
Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.
Blood
; 112(5): 2024-7, 2008 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18524988
10.
Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph-positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study.
Am J Hematol
; 85(3): 164-70, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20131302
11.
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.
N Engl J Med
; 355(23): 2408-17, 2006 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-17151364
12.
Recombinant differential anchorage probes that tower over the spatial dimension of intracellular signals for high content screening and analysis.
Anal Chem
; 81(23): 9590-8, 2009 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19873978
13.
Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
Exp Hematol
; 36(12): 1648-59, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18922616
14.
Proteasome inhibition specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins.
Cancer Biol Ther
; 6(4): 603-11, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17374988
15.
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
N Engl J Med
; 348(11): 994-1004, 2003 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-12637609
16.
Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.
Haematologica
; 92(10): 1327-34, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18024370
17.
[Transmission of medical information about patients who died of cancer to their heirs. Experience over 4 years and 57 cases]. / Transmission d'informations médicales aux ayants droit d'un malade décédé de cancer. Expérience de 4 ans et 57 dossiers.
Presse Med
; 36(10 Pt 1): 1350-3, 2007 Oct.
Artículo
en Francés
| MEDLINE | ID: mdl-17382513
18.
Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experience.
J Clin Oncol
; 23(30): 7676-84, 2005 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16186596
19.
Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment.
Haematologica
; 91(2): 162-8, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16461299
20.
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.
J Clin Oncol
; 20(21): 4324-30, 2002 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12409331